Oncosyne is pleased to welcome Dr. Tine Norman Alver as a new Lab Scientist, strengthening our growing scientific team.
Tine brings broad experience as a translational cancer researcher, with a strong background in working with patient-relevant preclinical models and key enabling technologies. Her hands-on expertise and scientific rigor will be an important asset as Oncosyne continues to advance its research and development efforts.
At Oncosyne, Tine will contribute across both clinical studies and R&D operations, supporting the expansion of the iCAN platform into new indications and the development of new high-throughput phenotyping assays. Her work will play a key role in translating complex biological insights into robust, scalable solutions.
We are excited to have Tine join the team and look forward to the impact she will help drive as we continue to grow and evolve Oncosyne’s technology platform.
